We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




Chromogenic Screening Plate Production for E. coli Increased

By LabMedica International staff writers
Posted on 15 Jun 2011
The current outbreak strain of the enterohemorrhagic Escherichia coli (EHCH) in Germany belongs to the Escherichia coli O104 serogroup. More...
Production and distribution of a chromogenic screening plate for rapid detection of extended spectrum β-lactamase-producing (ESBL) organisms, such as E. coli O104, has been increased.

In the past, most outbreaks of hemolytic uremic syndrome (HUS) have been associated with E. coli O157, but the current outbreak strain belongs to the E. coli O104 serogroup. The causative strain produces Shiga toxin 2 and shows high resistance to 3rd generation cephalosporins (due to the ESBL resistance mechanism), as well as broad antimicrobial resistance to, among others, trimethoprim/sulphonamide and tetracycline.

The Oxoid (Basingstoke, England) and Remel (Lenexa, KS, USA) include culture on Oxoid brilliance ESBL agar, which gives results within 24 hours.

Dr. Roger Stephan, Institute for Food Safety and Hygiene, University of Zurich (Switzerland), suggested a diagnostic strategy based on the capability of the VTEC O104 outbreak strain to produce an ESBL. He commented, "Positive fecal samples or food enrichment cultures can be streaked onto Brilliance ESBL agar. On this medium, ESBL-producing E. coli appear as blue colonies after 24 hr. incubation. Suspect colonies will then be confirmed by [polymerase chain reaction] PCR for the vtx genes. Since the prevalence of ESBL-producing E. coli in healthy people and food items should be low, this could really improve chances to isolate the strains responsible for the positive PCR screening."

Other methods of identification include direct toxin detection using the Remel ProSpecT Shiga Toxin E. coli microplate assay; isolation on media, such as Oxoid MacConkey Agar; toxin detection using the Oxoid VTEC-RPLA kit, following growth on Oxoid brain heart infusion agar; antimicrobial susceptibility testing on Oxoid Iso-Sensitest agar or Mueller-Hinton agar with cefpodoxime combination discs and identification using the DuPont Qualicon RiboPrinter microbial characterization system.

Oxoid and Remel are brands of Thermo Fisher Scientific.

Related Links:
Oxoid
Remel
Institute for Food Safety and Hygiene, University of Zurich


Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Serological Pipet Controller
PIPETBOY GENIUS
New
HAV Rapid Test
OnSite HAV IgG/IgM Rapid Test
New
See-Saw Rocking Shaker
SH-200D-S-L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Gut microbes may help in recognizing and treating pancreatic cancer (Photo courtesy of Adobe Stock)

Gut Microbes Could Enable Early Detection and Treatment of Pancreatic Cancer

Pancreatic cancer remains one of the most serious and challenging diseases in oncology due to its difficulty in detection and limited treatment options. Now, a new international collaborative study suggests... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Industry

view channel
Image: The knowledge transfer partnership will further develop technology to rapidly diagnose serious and high-risk infectious diseases (Photo courtesy of Aston University)

Aston University and BG Research Partner to Commercialize Groundbreaking Medical Diagnostic

Technology that can rapidly diagnose high-consequence infectious diseases will take a major step forward towards commercialization, thanks to a new partnership. A Knowledge Transfer Partnership (KTP)... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.